Remove 2024 Remove Plaque Remove Stent
article thumbnail

HonorHealth Research Institute First in Southwest to Implant New Stroke Prevention Stent

DAIC

The Neuroguard Integrated Embolic Protection (IEP) system is an experimental treatment for carotid artery stenosis, also known as carotid artery disease, a condition in which fatty-waxy deposits known as plaque builds up and blocks the normal flow of blood in the large arteries on either side of the neck. Designed by Raleigh, N.C.-based

Stent 111
article thumbnail

Preventive Percutaneous Coronary Intervention for High-Risk Coronary Plaques Reduces Cardiac Events

DAIC

These new findings suggest that people with high-risk plaques that are likely to rupture could benefit from the procedure as a pre-emptive measure rather than waiting for a heart attack or other severe reduction in blood flow to occur. During PCI, an operator inserts a stent into a blocked artery through a catheter in the groin or arm.

Plaque 111
article thumbnail

Abbott Enters IVL Burgeoning Segment

CardiacWire

IVL is a minimally invasive medical catheter-based procedure that treats calcified plaque in blood vessels. With the FDA nod, Abbott can now evaluate the IVL system in treating severe calcification in coronary arteries prior to stenting.

Plaque 59
article thumbnail

Elixir Medical Granted FDA Breakthrough Device Designation for DynamX Bioadaptor

DAIC

Image courtesy: Getty Images christine.book Tue, 06/18/2024 - 11:07 June 18, 2024 — Elixir Medical has announced the company’s novel bioadaptive implant, DynamX Sirolimus-Eluting Coronary Bioadaptor System, has been granted Breakthrough Device Designation by the U.S. of the U.S. population. of the U.S. population.

article thumbnail

Association between the neutrophil-to-lymphocyte ratio and in-stent neoatherosclerosis and plaque vulnerability: An optical coherence tomography study

Journal of Cardiovascular Pharmacology

This study aimed to explore the relationship between in-stent neoatherosclerosis (ISNA) and the neutrophil-to-lymphocyte ratio (NLR) in patients with in-stent restenosis (ISR) following drug-eluting stent (DES) implantation. Copyright © 2024 The Author(s). Published by Wolters Kluwer Health, Inc.

Stent 40
article thumbnail

Silk Road Medical Expands TCAR Portfolio with Launch of Tapered ENROUTE Transcarotid Stent System

DAIC

milla1cf Fri, 03/08/2024 - 21:58 March 8, 2024 — Silk Road Medical, Inc., a company focused on reducing the risk of stroke and its devastating impact, today announced that it has launched its Tapered ENROUTE Transcarotid Stent System to hospitals in the United States.

Stent 59
article thumbnail

Boston Scientific Receives FDA Approval for the AGENT Drug-Coated Balloon

DAIC

milla1cf Fri, 03/01/2024 - 08:50 March 1, 2024 — Boston Scientific Corporation today announced it has received U.S. Food and Drug Administration ( FDA ) approval for the AGENT Drug-Coated Balloon (DCB), which is indicated to treat coronary in-stent restenosis (ISR) in patients with coronary artery disease. vs. 28.7%; P=0.006).

Stent 105